Fernandez, Ana .
HRN: 22-12-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
CEFTRIAXONE 1G (VIAL)
12/29/2022
01/04/2023
IV
2g
OD
F/C Hepatic Encephalopathy, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes